Zevra Therapeutics (ZVRA) EBITDA (2014 - 2026)
Zevra Therapeutics' EBITDA was $11.96 million in Q3 2026, up 163.7% from $4.54 million a year earlier but down 30.2% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) EBITDA (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Zevra Therapeutics' EBITDA was $91.29 million through Sep 30, 2026; for FY2025, it came in at -$58.89 million.
- In earlier years, EBITDA was -$80.61 million in FY2024, -$48.6 million in FY2023, -$41.62 million in FY2022 and $8.14 million in FY2021.
- Quarterly EBITDA has moved between -$69.39 million (Q2 2025) and $52.51 million (Q1 2026) over five years.
- Per Business Quant data, ZVRA's EBITDA in the three quarters before Q3 2026 was $17.14 million (Q2 2026), $52.51 million (Q1 2026) and $9.68 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn | 11.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 11.96 Mn |
| Jun 30, 2026 | 17.14 Mn |
| Mar 31, 2026 | 52.51 Mn |
| Dec 31, 2025 | 9.68 Mn |
| Sep 30, 2025 | 4.54 Mn |
| Jun 30, 2025 | -69.39 Mn |
| Mar 31, 2025 | -3.71 Mn |
| Dec 31, 2024 | -13.77 Mn |
| Sep 30, 2024 | -25.69 Mn |
| Jun 30, 2024 | -22.23 Mn |
| Mar 31, 2024 | -18.92 Mn |
| Dec 31, 2023 | -14.37 Mn |
| Sep 30, 2023 | -15.30 Mn |
| Jun 30, 2023 | -6.17 Mn |
| Mar 31, 2023 | -12.75 Mn |
| Dec 31, 2022 | -9.01 Mn |
| Sep 30, 2022 | -6.23 Mn |
| Jun 30, 2022 | -24.59 Mn |
| Mar 31, 2022 | -1.79 Mn |
| Dec 31, 2021 | -2.78 Mn |
API Access
Zevra Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();